HOXB6 and Alzheimer disease: Moreover, one recent epigenome-wide association study identified that HOXB6 gene was robustly hypermethylated in MCI and AD blood samples compared with healthy controls (Roubroeks et al., 2020), suggesting HOXB6 gene hypermethylation signature may be potential biomarker for the diagnosis of MCI and AD.